Document is current
Any future updates will be listed below
-
Authors
Verver, Danielle https://orcid.org/0000-0003-0034-3575
Grünhagen, Dirk J.
van Akkooi, Alexander C. J.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
van den Eertwegh, Alfonsus J. M.
de Groot, Jan Willem B.
Boers-Sonderen, Marye J.
Haanen, John B. A. G.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Rozemarijn S.
Suijkerbuijk, Karijn P. M.
Tije, Albert J.ten
Vreugdenhil, Gerard
Verhoef, Cornelis
van der Veldt, Astrid A. M.
-
Funding
Funding for this research was provided by:
ZonMw (836002002)
Roche Nederland B.V
Bristol-Myers Squibb
GlaxoSmithKline/Novartis
Merck Sharp & Dohme
- License Information
-
More Information
Article History
Received: 23 November 2020
Accepted: 20 January 2021
First Online: 27 March 2021
Compliance with ethical Standards
:
: AvA has consultancy/advisory relationships with Amgen, Bristol-Myers Squibb, Novartis, MSD-Merck, Merck-Pfizer, Sanofi, 4SC and has received research grants not related to this paper from Amgen, Bristol-Myers Squibb, Novartis, Merck-Pfizer. MA has consultancy/advisory relationships with Pfizer, BMS, MERCK, Sanofi, Astellas, Pierre fabre, and Novartis. AvdE has advisory relationships with Amgen, Bristol-Myers Squibb, Roche, Novartis, MSD, Pierre Fabre. JdG has advisory relationships with Bristol-Myers Squibb, Roche, Pierre Fabre, Servier, MSD, Novartis. JH has advisory relationships with Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Celsius Therapeutics, GSK, Immunocore, Ipsen, MSD, Merck Serono, Novartis, Neon Therapeutics, Pfizer, Roche/Genentech, Sanofi, Seattle Genetics and has received research grants not related to this paper from Novartis, Bristol-Myers Squibb, MSD, Neon Therapeutics. GH consultancy/advisory relationships with Amgen, Bristol-Myers Squibb, Roche, MSD, Pfizer, Novartis and has received research grants not related to this paper from Bristol-Myers Squibb, Seerave. EK has consultancy/advisory relationships with Bristol-Myers Squibb, Novartis, Merck, Pierre Fabre and received research grants not related to this paper from Bristol-Myers Squibb. KS has advisory relationships with Bristol-Myers Squibb, Roche, Novartis, MSD, Pierre Fabre. AvdV has consultancy relationships with Bristol-Myers Squibb, MSD, Roche, Novartis, Pierre Fabre, Pfizer, Sanofi, Ipsen, Eisai. All grants were paid to the institutions and not related to this work. All remaining authors have declared no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of HELSINKI and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.
